Altimmune's total assets for Q3 2025 were $218.45M, an increase of 14.76% from the previous quarter. ALT total liabilities were $32.85M for the fiscal quarter, a 13.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.